Cargando…

Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases

Bone metastasis remains a major cause of death in cancer patients, and current therapies for bone metastatic disease are mainly palliative. Bone metastases arise after cancer cells have colonized the bone and co-opted the normal bone remodeling process. In addition to bone-targeted therapies (e.g.,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Chirayu M., Wadas, Thaddeus J., Shiozawa, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070008/ https://www.ncbi.nlm.nih.gov/pubmed/33918705 http://dx.doi.org/10.3390/molecules26082162

Ejemplares similares

Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases
por: Longo, John, et al.
Publicado: (2013)

Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides
por: Li, Wei Bo, et al.
Publicado: (2022)

IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017)

Development of Targeted Alpha Particle Therapy for Solid Tumors
por: Tafreshi, Narges K., et al.
Publicado: (2019)

Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies
por: Abou, Diane S., et al.
Publicado: (2022)

Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
por: Pandya, Darpan N., et al.
Publicado: (2017)

A Projection-Domain Low-Count Quantitative SPECT Method for α-Particle-Emitting Radiopharmaceutical Therapy
por: Li, Zekun, et al.
Publicado: (2023)

Osteoblasts derived from mouse mandible enhance tumor growth of prostate cancer more than osteoblasts derived from long bone
por: Eber, Matthew R., et al.
Publicado: (2020)

Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics
por: Kauffman, Nathan, et al.
Publicado: (2023)

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
por: Pallares, Roger M., et al.
Publicado: (2022)

A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity
por: Tichacek, Christopher J., et al.
Publicado: (2019)

Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
por: Batra, Vandana, et al.
Publicado: (2022)

[(123)I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
por: Chan, Chung Ying, et al.
Publicado: (2023)

PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials
por: Ramnaraign, Brian, et al.
Publicado: (2023)

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
por: El Fakiri, Mohamed, et al.
Publicado: (2021)

VCAM-1 targeted alpha-particle therapy for early brain metastases
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2020)

Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases
por: Park, Sun H., et al.
Publicado: (2018)

Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy
por: Rusckowski, Mary, et al.
Publicado: (2016)

Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020)

Stroma Targeting Nuclear Imaging and Radiopharmaceuticals
por: Shetty, Dinesh, et al.
Publicado: (2012)

(18)F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2014)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2018)

Alpha-Emitter Radiopharmaceuticals and External Beam Radiotherapy: A Radiobiological Model for the Combined Treatment
por: Sarnelli, Anna, et al.
Publicado: (2022)

Composition of particles emitted at large p$_{T}$ and medium angles in pp, dd, and alpha.alpha collisions at the ISR
por: Breakstone, A, et al.
Publicado: (1984)

Protection from contamination by (211)At, an enigmatic but promising alpha-particle-emitting radionuclide
por: Ohnuki, Kazunobu, et al.
Publicado: (2022)

Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

The angular distributions of $\alpha$-particles emitted by oriented nuclei and their relation to nuclear structure and deformation
por: Schuurmans, P, et al.
Publicado: (1997)

Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes
por: Benabdallah, Nadia, et al.
Publicado: (2021)

Imaging of Fibroblast Activation Protein Alpha Expression in a Preclinical Mouse Model of Glioma Using Positron Emission Tomography
por: Pandya, Darpan N., et al.
Publicado: (2020)

Recent Progress toward Microfluidic Quality Control Testing of Radiopharmaceuticals
por: Ha, Noel S., et al.
Publicado: (2017)

CD46 targeted (212)Pb alpha particle radioimmunotherapy for prostate cancer treatment
por: Li, Jun, et al.
Publicado: (2023)

Treatment of Prostate Cancer with CD46-targeted (225)Ac Alpha Particle Radioimmunotherapy
por: Bidkar, Anil P., et al.
Publicado: (2023)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Radiopharmaceuticals in monitoring cancer
por: Britton, Keith E., et al.
Publicado: (2015)

Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s5aekj56l41phto8c8r2qgto1d